AusperBio Reports Sustained Functional Cure Up to 15 Months Off All HBV Treatment for Chronic Hepatitis B Patients

Long-term follow-up supports AHB-137 as a potential finite-duration therapy; data featured in two late-breaking oral presentations at AASLD The Liver Meeting® 2026